Before, during and after, what else to say about the CAD at the debut?

Authors

  • Mariana Prieto Juan P. Garrahan Pediatric Hospital, Autonomous City of Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/diab.v57i3Sup.651

Keywords:

diabetic ketoacidosis, treatment

Abstract

Biochemical criteria to diagnose diabetic ketoacidosis (DKA) include:

  • Serum bicarbonate <18 mmol/L.
  • Infusion of initial fluid bolus(es) over 20–30 min.
  • Promoting a rise in serum sodium concentrations during DKA treatment is no longer considered necessary.
  • Increased emphasis on differences in treatment recommendation for HHS and mixed presentation of DKA and HHS (hyperosmolar DKA) compared to standard DKA treatment, by ISPAD 2022, we have GAP guide whit Biochemical criteria to diagnose diabetic ketoacidosis (DKA), we have our guides GAP with certain differences.

Author Biography

Mariana Prieto, Juan P. Garrahan Pediatric Hospital, Autonomous City of Buenos Aires, Argentina

Pediatrician specialized in Child Nutrition

References

I. ISPAD. Clinical Practice Consensus Guidelines 2022.

II. GUIAS GAP. Hospital de Pediatría J. P. Garrahan.

III. Kuppermann N, et al. Clinical trial of fluid infusion rates for pediatric diabetic ketoacidosis. N Engl J Med 2018 Jun 14;378(24):2275-2287.

Suplemento XI Jornadas Nacionales de Diabetes

Downloads

Published

2023-08-30

How to Cite

Prieto, M. (2023). Before, during and after, what else to say about the CAD at the debut?. Journal of the Argentine Society of Diabetes, 57(3Sup), 7–7. https://doi.org/10.47196/diab.v57i3Sup.651

Issue

Vol. 57 No. 3Sup (2023): September/December 2023

Section

4 VOICES in 10 MINUTES: Before, during and after, what else to say about diabetic ketoacidosis on debut?

License

Copyright (c) 2023 on behalf of the authors. Reproduction rights: Argentine Diabetes Society

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.

La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.

Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.

 

Most read articles by the same author(s)